Medical Analysis Systems, Inc.
FDA 510(k) medical device clearances.
Top product codes for Medical Analysis Systems, Inc.
Recent clearances by Medical Analysis Systems, Inc.
1–100 of 107- K042717 — MAS, DADE AND LIQUID ASSAYED DIABETES CONTROL
- K041194 — ABBOTT ARCHITECT STAT TROPONIN I LIQUID ASSAYED CARDIAC MARKER CONTROL LEVEL L, M AND H
- K040880 — MAS CARDIOIMMUNE TL LIQUID ASSAYED CARDIAC MARKER CONTROL, LEVELS 1,2 AND 3
- K032826 — MAS PAR TDM
- K032335 — MAS CARDIOIMMUNE PROBNP, MAS CARDIOIMMUNE TL
- K031890 — MAS BILIRUBIN LIQUID ASSAYED BILIRUBIN CONTROL
- K031392 — MAS TOX AMMONIA CONTROLLIQUID ASSAYED TOX AMMONIA CONTROL
- K031441 — URICHEMTRAK LIQUID ASSAYED URINE CONTROL
- K031364 — MAS CARDIOLMMUNE PROBNP LIQUID ASSAYED CARDIAC MARKER CONTROL LEVEL 1, 2 AND 3
- K030942 — MAS CHEMTRAK H & DADE MONI-TROL H LIQUID ASSAYED CHEMISTRY CONTROL
- K030679 — MAS LIPID LEVEL 1 AND 2
- K023669 — MAS CARDIOIMMUNE TL LOW LEVEL LIQUID ASSAYED CARDIAC MARKER CONTROL, DADE CARDIAC TL LOW LEVEL LIQUID ASSAYED CARDIAC MA
- K023867 — MAS T-MARKER, LEVEL 1,2 AND 3, DADE SPECIAL-T MARKER, LEVEL 1,2 AND 3
- K023928 — MAS UA CONTROL LIQUID ASSAYED URINALYSIS CONTROL, DADE ASSAYED URINALYSIS CONTROL
- K023307 — MAS DIABETES CONTROL - LYOPHILIZED ASSAYED DIABETES CONTROL
- K021155 — MAS UA CONTROL, DADE UA CONTROL- LIQUID ASSAYED URINALYSIS CONTROL
- K013995 — MODIFICATION TO MAS CARDIOLMMUNE TL; DADE CARDIAC TL
- K013734 — MAS LIPID CONTROL, LIQUID ASSAYED LIPID CONTROL, LEVEL 1 AND 2, DADE LIPID CONTROL, LIQUID ASSAYED LIPID CONTROL, LEVEL
- K011731 — TRI-POINT LIQUIMMUNE LIQUID ASSAYED CONTROL LEVELS 1,2, AND 3
- K011548 — CHEMTRAK PLATINUM COMPREHENSIVE LIQUID ASSAYED CHEMISTRY AND TDM CONTROL LEVELS 1, 2, 3
- K010111 — CARDIOIMMUNE TL CARDIAC MARKER CONTROL LEVELS 1, 2, 3, AND MULTI-PACK
- K001758 — DADE TRU-LIQUID MONI-TROL CHEMISTRY CONTROL LEVELS 1, MID, 2, AND S (ASSAYED)
- K993546 — TRI-POINT, LIQUIMMUNE LIQUID ASSAYED IMMUNOASSAY CONTROL, LEVELS 1, 2, AND 3
- K992829 — CASCADE LIQUID COAGULATION CONTROL LEVELS 1, 2, AND 3
- K992430 — CARDIOIMMUNE CARDIAC MARKER CONTROL LEVELS 1,2, AND 3
- K984277 — CARDIOIMMUNE CARDIAC MARKER CONTROL LEVELS 1,2, AND 3
- K983127 — OPIATES 2000 LIQUID OPIATES DRUGS OF ABUSE CONTROL LEVELS G2 AND G3
- K981933 — URICHEMTRAK LIQUID ASSAYED CONTROL LEVELS 1 AND 2
- K982024 — OPIATES 2000 LIQUID OPIATES DRUGS OF ABUSE CONTROL LEVELS 2 AND 3
- K980514 — CHEMTRAK PLATINUM COMPREHENSIVE LIQUID ASSAYED CHEMISTRY AND TDM CONTROL LEVEL 1, MODEL AP11001, LEVEL 2, MODEL AP22002
- K973451 — MAS LIQUID URINALYSIS CONTROL LEVEL 1, LEVEL 2 AND LEVEL 3
- K970856 — CARDIOISOZYME, CK/LD ISOENZYME CONTROL
- K971058 — DOA-XSE, LIQUID DRUGS OF ABUSE CONTROL LEVELS 2,3, AND 4 (SDOA- 202,303,404)
- K970976 — CARDIOIMMUNE CARDIAC MARKER CONTROL, LEVELS 1,2 AND 3
- K960824 — IMMUNOLOGY CONTROL
- K960862 — LIPID CONTROL
- K954323 — MAS LIQUID URINALYSIS CONTROL
- K954322 — TRI-POINT LIQUIMMUNE LIQUID ASSAYED IMMUNOASSAY CONTROL
- K952877 — CSF LIQUID CEREBROSPINAL FLUID CONTROL
- K951057 — MAS LIQUID ASSAYED ALCOHOL/AMMONIA CONTROL LEVEL 1 AND 2
- K944525 — LIQUID ASSAYED TUMOR MARKER CONTROL LEVEL 1, LEVEL 2, LEVEL 3
- K941328 — TRAK LIQUID CEREBROSPINAL FLUID CONTROL LEVELS 1 & 2
- K940433 — DOA LIQUID DRUGS OF ABUSE CONTROLS LEVLS 2,3,& 4,G2,G3,& G4
- K936166 — CHEMTRAK LIQUID UNASSAYED THERAPEUTIC DRUG CONTROLS
- K934498 — DOA LIQUID DRUGS OF ABUSE CONTROLS
- K934650 — CEDIA DAU CONTROLS
- K935062 — MAS LIQUID URINALYSIS CONTROL
- K934056 — TRI-POINT BRAND LIQUIMMUNE IMMUNOASSAY CONTR 1,2 & 3
- K931366 — TRI-POINT LIQUIMMUNE IMMUONASSAY CONTROL, L-1,2,3
- K926320 — REFLAB SYSTEM PACK LIQUID CO2 REAGENT
- K920291 — MONI-TROL-L AND MONI-TROL-XL
- K920397 — REFLAB SYSTEM PACK LIQUID FRUCTOSAMINE REAGENT
- K914204 — TRI-POINT LIQUIMMUNE LIGAND CONTROL LEVELS 1,2,3
- K914069 — REFLAB(TM) BRAND SYST PK LIQ REAGENT, APOLIPOP A-1
- K912749 — REFLAB(TM) BR SYST PACK LIQ REAG, APOLIPOPROTEIN B
- K910333 — CHALLENGE (TM) LIQ THERA DRUG CONTROLS
- K904905 — DOA LIQUID MULTI-ANALYTE DRUGS OF ABUSE CONTROLS
- K904141 — TDM PLUS XL ENHANCED LIQ DRUG CONTROL I,II,III
- K903310 — CHALLENGE(TM) BRAND LIQ MULTI-ANALYTE LINEAR CONTR
- K903190 — MONI-TROL XL AND L UNASSAYED LIQUID CHEMISTRY
- K903225 — CHALLENGE BRAND LIQUID MULTI-ENZYME LINEARITY CONT
- K900902 — IRON LIQUID STABLE REAGENT
- K900259 — DIRECT BILIRUBIN REAGENT
- K893730 — DIRECT BILIRUBIN REAGENT
- K892393 — ACID PHOSPHATASE REAGENT
- K891155 — IRON REAGENT
- K891355 — MAGNESIUM REAGENT
- K885078 — LIPASE SR LIQUID STABLE REAGENT SET
- K890317 — TOTAL PROTEIN REAGENT
- K885176 — AMYLASE SR LIQUID STABLE REAGENT SET
- K883543 — HDL-CHOLESTEROL PRECIPITATING REAGENT
- K880152 — PAR(TM) BRAND DRUG OF ABUSE CONTROLS
- K881300 — MAGNESIUM LIQUID STABLE REAGENT SET
- K881200 — CHLORIDE LIQUID STABLE REAGENT SET
- K870586 — TDCONTROL LIQUID MULTI-ANALYTE THERAPEUTIC DRUG
- K862733 — AMYLASE SR LIQUID STABLE REAGENT SET
- K863095 — ACE II (TRI-LEVEL)
- K861413 — BILIRUBIN*SR (TOTAL) LIQUID STABLE REAGENT SET
- K855041 — CALCIUM LIQUID STABLE REAGENT SET
- K853868 — ALBUMIN SR LIQUID STABLE REAGENT SET
- K853464 — GLUCOSE SR LIQUID STABLE REAGENT SET
- K852461 — CHEMTRAK LIQUID MULTI-ANALYTE CALIBRATOR, MUL-SET
- K852103 — INORGANIC PHOSPHORUS LIQUID STABLE REAGENT INORGAN
- K851849 — CREATINE LIQUID STABLE REAGENT SET
- K851877 — TOTAL PROTEIN LIQUID STABLE REAGENT SET
- K851670 — CHEM TRAK TRI-POINT LIQUID BILIRUBIN CALIBRATOR,I/
- K834518 — LIQUID STABLE TRIGLYCERIDES REAGENT SET
- K833097 — CHEM TRAK LIQUID BILIRUBIN CONTROL
- K832941 — BUN LIQUID STABLE REAGENT SET
- K821382 — CHEMISTRY CONTROL/STANDARD
- K813511 — URIC-ACID
- K781718 — ALP REAGENT SET, ALKALINE PHOSPHATASE
- K781719 — CPK REAGENT SET, NAD REDUCTION
- K781720 — HBDH ENZYME KINETIC REAGENT SET
- K781721 — REAGENT SET, CHOLESTEROL
- K781722 — REAGENT SET, TOTAL PROTEIN
- K781723 — GLUCOSE HEXOKINASE, AUTO K
- K781724 — NAD REDUCTION METHOD, LACTATE PYRIVATE
- K781725 — REAGENT SET, U.V. ENZMATIC KINETIC, SGOT
- K781726 — REAGENT SET, SGPT SERUM GLUTAMIC
Data sourced from openFDA. This site is unofficial and independent of the FDA.